WHO SMART Guidelines - HIV
0.3.0 - ci-build
WHO SMART Guidelines - HIV - Local Development build (v0.3.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Active as of 2024-10-30 |
{
"resourceType" : "ValueSet",
"id" : "HIV.D.DE1010",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablevalueset"🔗 ,
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablevalueset"🔗 ,
"http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-computablevalueset"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet HIV.D.DE1010</b></p><a name=\"HIV.D.DE1010\"> </a><a name=\"hcHIV.D.DE1010\"> </a><a name=\"HIV.D.DE1010-en-US\"> </a><ul><li>Include these codes as defined in <a href=\"CodeSystem-HIVConcepts.html\"><code>http://smart.who.int/hiv/CodeSystem/HIVConcepts</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46D.46DE1011\">HIV.D.DE1011</a></td><td>Isoniazid</td><td>Client is currently taking isoniazid</td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46D.46DE1012\">HIV.D.DE1012</a></td><td>Rifampicin</td><td>Client is currently taking rifampicin</td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46D.46DE1013\">HIV.D.DE1013</a></td><td>Rifabutin</td><td>Client is currently taking rifabutin</td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46D.46DE1014\">HIV.D.DE1014</a></td><td>Ethambutol</td><td>Client is currently taking ethambutol</td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46D.46DE1015\">HIV.D.DE1015</a></td><td>Levofloxacin</td><td>Client is currently taking levofloxacin</td></tr><tr><td><a href=\"CodeSystem-HIVConcepts.html#HIVConcepts-HIV.46D.46DE1016\">HIV.D.DE1016</a></td><td>Pyrazinamide</td><td>Client is currently taking pyrazinamide, a first-line anti-tuberculosis drug</td></tr></table></li></ul></div>"
},
"url" : "http://smart.who.int/hiv/ValueSet/HIV.D.DE1010",
"version" : "0.3.0",
"name" : "HIVDDE1010",
"title" : "TB treatment regimen composition ValueSet",
"status" : "active",
"experimental" : true,
"date" : "2024-10-30T19:04:31+00:00",
"publisher" : "WHO",
"contact" : [
{
"name" : "WHO",
"telecom" : [
{
"system" : "url",
"value" : "http://who.int"
}
]
}
],
"description" : "Value set of tB drugs currently being taken by the client",
"compose" : {
"include" : [
{
"system" : "http://smart.who.int/hiv/CodeSystem/HIVConcepts",
"concept" : [
{
"code" : "HIV.D.DE1011",
"display" : "Isoniazid"
},
{
"code" : "HIV.D.DE1012",
"display" : "Rifampicin"
},
{
"code" : "HIV.D.DE1013",
"display" : "Rifabutin"
},
{
"code" : "HIV.D.DE1014",
"display" : "Ethambutol"
},
{
"code" : "HIV.D.DE1015",
"display" : "Levofloxacin"
},
{
"code" : "HIV.D.DE1016",
"display" : "Pyrazinamide"
}
]
}
]
}
}